Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

The tetraspanin CD53 protects stressed hematopoietic stem cells via promotion of DREAM complex–mediated quiescence

Zev J. Greenberg, Luana Chiquetto Paracatu, Darlene A. Monlish, Qian Dong, Michael Rettig, Nate Roundy, Rofaida Gaballa, Weikai Li, Wei Yang, Cliff J. Luke, Laura G. Schuettpelz

Blood (2023) 141 (10): 1180–1193.

https://doi.org/10.1182/blood.2022016929

Published: 2023

Includes: Supplemental data

Journal Articles

The Tetraspanin CD53 Promotes CXCR4 Signaling to Facilitate B Cell Migration

Mousumi Chakraborty, Zev J. Greenberg, Eric J. Duncavage, Nate Roundy, Qian Dong, Laura G. Schuettpelz

Blood (2022) 140 (Supplement 1): 8345–8346.

https://doi.org/10.1182/blood-2022-166906

Published: 2022

Journal Articles

The Role of Stathmin-1 in the Regulation of Hematopoietic Stem Cells

Luana Chiquetto Paracatu, Qian Dong, Zev J. Greenberg, Liana Valin, Nate Roundy, Christine R Zhang, Grant A Challen, Cliff Luke, Stephen M. Sykes, Laura G. Schuettpelz

Blood (2022) 140 (Supplement 1): 5734–5735.

https://doi.org/10.1182/blood-2022-166665

Published: 2022

Journal Articles

The Tetraspanin CD53 Protects Hematopoietic Stem Cells Following Cellular Stress through Induction of DREAM Complex-Mediated Quiescence

Zev J. Greenberg, Darlene A. Monlish, Qian Dong, Luana Chiquetto Paracatu, Michael P. Rettig, Wei Yang, Weikai Li, Laura G. Schuettpelz

Blood (2021) 138 (Supplement 1): 295.

https://doi.org/10.1182/blood-2021-151010

Published: 2021

Journal Articles

The Tetraspanin CD53 Regulates Early B Cell Development By Promoting IL-7R Signaling

Zev J. Greenberg, BS, Darlene A. Monlish, PhD, Rachel L. Bartnett, Jeffrey J. Bednarski, MD PhD, Laura G. Schuettpelz, MD PhD

Blood (2019) 134 (Supplement_1): 79.

https://doi.org/10.1182/blood-2019-131641

Published: 2019

Journal Articles

Regulation of Homeostatic and Malignant B Cell Development By the Tetraspanin CD53

Zev J. Greenberg, BS, Darlene A. Monlish, PhD, Rachel L. Bartnett, Laura G. Schuettpelz, MD PhD

Blood (2018) 132 (Supplement 1): 3699.

https://doi.org/10.1182/blood-2018-99-111957

Published: 2018

Journal Articles

Differential Effects of TLR1/2 and TLR2/6 Signaling on Normal and Premalignant Hematopoietic Stem and Progenitor Cells

Darlene A. Monlish, PhD, Zev J. Greenberg, BS, Sima T. Bhatt, MD, Dagmar Ralphs, John L. Keller, BS, Lauren Bendesky, Laura G. Schuettpelz, MD PhD

Blood (2018) 132 (Supplement 1): 1806.

https://doi.org/10.1182/blood-2018-99-119719

Published: 2018

Journal Articles

Loss of Toll-like receptor 2 results in accelerated leukemogenesis in the NUP98-HOXD13 mouse model of MDS

Darlene A. Monlish, Sima T. Bhatt, Eric J. Duncavage, Zev J. Greenberg, John L. Keller, Molly P. Romine, Wei Yang, Peter D. Aplan, Matthew J. Walter, Laura G. Schuettpelz

Blood (2018) 131 (9): 1032–1035.

https://doi.org/10.1182/blood-2017-08-801944

Published: 2018

Includes: Supplemental data

Journal Articles

Treatment of High Risk DLBCL with DA-R-EPOCH in Those Unable to Tolerate Intensive Chemotherapy: Well-Tolerated and Effective, but Inadequate in Double/Triple Hit or Expressing DLBCL

Lori A. Leslie, MD, Sejal Kothadia, MD, Ewelina Protomastro, MS, Patricia J Greenberg, Tracy Andrews, PhD, Ann McNeill, ANP, Hoshiyuki Iida, Alan P Skarbnik, MD, Xiao Yang, Pritish K. Bhattacharyya, MD, Kar Fai Chow, MD, Stuart L. Goldberg, MD, Andrew L. Pecora, MD, Tatyana A Feldman, MD, Andre Goy, MD

Blood (2017) 130 (Supplement 1): 4163.

https://doi.org/10.1182/blood.V130.Suppl_1.4163.4163

Published: 2017

Journal Articles

Loss of Toll-like Receptor 2 Results in Accelerated Leukemogenesis in the NUP98-HOXD13 Mouse Model of MDS

Darlene A. Monlish, PhD, Sima T. Bhatt, MD, Eric J. Duncavage, MD, Zev J. Greenberg, BS, John L. Keller, BS, Matthew J. Walter, MD, Laura G. Schuettpelz, MD PhD

Blood (2017) 130 (Supplement 1): 48.

https://doi.org/10.1182/blood.V130.Suppl_1.48.48

Published: 2017

Journal Articles

Risk of Monoclonal Gammopathy of Undetermined Significance in First-Degree Relatives of Multiple Myeloma Cases By Cytogenetic Subtype

Alyssa I. Clay, PhD, Abdul Rishi, MBBS, Shaji Kumar, MD, S. Vincent Rajkumar, MD, Alexandra J. Greenberg, PhD MPH, Dirk R Larson, MS, Megan M. O'Byrne, MS, Susan L. Slager, PhD, Celine M. Vachon, PhD

Blood (2016) 128 (22): 4425.

https://doi.org/10.1182/blood.V128.22.4425.4425

Published: 2016

Journal Articles

Responsiveness Of Cytogenetically Discrete Human Myeloma Cell Lines To Lenalidomide: Lack Of Correlation With Cereblon and Interferon Regulatory Factor 4 Expression Levels

Alexandra J Greenberg, Denise K Walters, PhD, Bonnie Kaye Arendt, Renee C. Tschumper, Shaji K. Kumar, MD, S. Vincent Rajkumar, MD, Diane F. Jelinek, PhD

Blood (2013) 122 (21): 1962.

https://doi.org/10.1182/blood.V122.21.1962.1962

Published: 2013

Journal Articles

Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics

Alexandra J. Greenberg, S. Vincent Rajkumar, Celine M. Vachon

Blood (2012) 119 (23): 5359–5366.

https://doi.org/10.1182/blood-2011-11-387324

Published: 2012

Journal Articles

An Experimental Model of Human Leukemic Meningitis in the Nude Rat

Tara A. Barone, Robert J. Plunkett, Philip Hohmann, Agnieszka Lis, Norman Glenister, Maurice Barcos, Peter T. Ostrow, Phyllis M. Spence, Steven J. Greenberg

Blood (1997) 90 (1): 298–305.

https://doi.org/10.1182/blood.V90.1.298

Published: 1997

Journal Articles

Proteolysis of platelet glycoprotein Ib by plasmin is facilitated by plasmin lysine-binding regions

B Adelman, AD Michelson, J Greenberg, RI Handin

Blood (1986) 68 (6): 1280–1284.

https://doi.org/10.1182/blood.V68.6.1280.1280

Published: 1986

Journal Articles

Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions

B Adelman, AD Michelson, J Loscalzo, J Greenberg, RI Handin

Blood (1985) 65 (1): 32–40.

https://doi.org/10.1182/blood.V65.1.32.32

Published: 1985

Journal Articles

Factors affecting fibrinopeptide-A levels in patients with venous thromboembolism during anticoagulant therapy

I Yudelman, J Greenberg

Blood (1982) 59 (4): 787–792.

https://doi.org/10.1182/blood.V59.4.787.787

Published: 1982

NARROW

The tetraspanin CD53 protects stressed hematopoietic stem cells via promotion of DREAM complex–mediated quiescence

The Tetraspanin CD53 Promotes CXCR4 Signaling to Facilitate B Cell Migration

The Role of Stathmin-1 in the Regulation of Hematopoietic Stem Cells

The Tetraspanin CD53 Protects Hematopoietic Stem Cells Following Cellular Stress through Induction of DREAM Complex-Mediated Quiescence

The Tetraspanin CD53 Regulates Early B Cell Development By Promoting IL-7R Signaling

Regulation of Homeostatic and Malignant B Cell Development By the Tetraspanin CD53

Differential Effects of TLR1/2 and TLR2/6 Signaling on Normal and Premalignant Hematopoietic Stem and Progenitor Cells

Loss of Toll-like receptor 2 results in accelerated leukemogenesis in the NUP98-HOXD13 mouse model of MDS

Treatment of High Risk DLBCL with DA-R-EPOCH in Those Unable to Tolerate Intensive Chemotherapy: Well-Tolerated and Effective, but Inadequate in Double/Triple Hit or Expressing DLBCL

Loss of Toll-like Receptor 2 Results in Accelerated Leukemogenesis in the NUP98-HOXD13 Mouse Model of MDS

Risk of Monoclonal Gammopathy of Undetermined Significance in First-Degree Relatives of Multiple Myeloma Cases By Cytogenetic Subtype

Responsiveness Of Cytogenetically Discrete Human Myeloma Cell Lines To Lenalidomide: Lack Of Correlation With Cereblon and Interferon Regulatory Factor 4 Expression Levels

Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics

An Experimental Model of Human Leukemic Meningitis in the Nude Rat

Proteolysis of platelet glycoprotein Ib by plasmin is facilitated by plasmin lysine-binding regions

Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions

Factors affecting fibrinopeptide-A levels in patients with venous thromboembolism during anticoagulant therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only